Literature DB >> 13942482

In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells.

P PERLMANN, O BROBERGER.   

Abstract

Freshly isolated fetal human colon cells were labeled with (32)P-orthophosphate or (14)C-amino acids and exposed to white blood cells from children with ulcerative colitis or from healthy controls. Exposure of the colon cells to patients' white cells led to a rapid isotope release, significantly higher than that obtained with normal white cells. After 150 minutes of incubation, 75 per cent of the total isotope present was found in the media of the colitis samples but only 40 per cent in those of the controls. Consistent results were obtained with white blood cells from 14 patients and 18 healthy individuals. Similar results were obtained with either fresh white cells or with white cells aged for 12 to 18 hours and consisting to 60 to 70 per cent of lymphocytes and to 20 to 30 per cent of large mononuclear cells. No specific cytotoxic activity could be conferred onto normal white cells by pretreating them with patients' serum containing antibodies against colon antigen. The cytotoxic action of the patients' white cells was immunologically specific, since no difference from the controls was found in the isotope release when cells from other organs or animals were similarly treated. Preliminary experiments suggested that the patients' white cells could be desensitized by pretreating them with colon extract. For obtaining a significant cytotoxic effect of the patients' white cells, the presence of 10 to 20 per cent of fresh guinea pig or human serum in the incubation medium was required.

Entities:  

Keywords:  COLITIS, ULCERATIVE; COLON; LEUKOCYTES; TISSUE CULTURE

Mesh:

Substances:

Year:  1963        PMID: 13942482      PMCID: PMC2137644          DOI: 10.1084/jem.117.5.717

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Immune mechanisms in homotransplantation. I. The role of serum antibody and complement in the neutralization of lymphoma cells.

Authors:  H J WINN
Journal:  J Immunol       Date:  1960-05       Impact factor: 5.422

2.  The action of antibody and complement on mammalian cells.

Authors:  H GREEN; B GOLDBERG
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

3.  On the permeability to lissamine green and other dyes in the course of cell injury and cell death.

Authors:  B HOLMBERG
Journal:  Exp Cell Res       Date:  1961-01       Impact factor: 3.905

4.  In vitro studies of the interaction of lymph node and homologous tissue.

Authors:  R J SCOTHORNE; I NAGY
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

5.  Possible relationships between the cytotoxic effects of isoantibody and host cell function.

Authors:  D B AMOS
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

6.  Cell-bound antibodies in transplantation immunity.

Authors:  J H BERRIAN; L BRENT
Journal:  Ann N Y Acad Sci       Date:  1958-10-07       Impact factor: 5.691

7.  Homograft sensitivity. An expression of the immunologic origins and consequences of individuality.

Authors:  H S LAWRENCE
Journal:  Physiol Rev       Date:  1959-10       Impact factor: 37.312

8.  Cell injury in allergic inflammation.

Authors:  C B FAVOUR
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

9.  Tissue transplantation immunity.

Authors:  L BRENT
Journal:  Prog Allergy       Date:  1958

10.  In vitro studies of ulcerative colitis. I. Reactions of patients' serum with human fetal colon cells in tissue cultures.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

View more
  64 in total

1.  SERUM COMPLEMENT LEVELS IN ACTIVE ULCERATIVE COLITIS.

Authors:  J FLETCHER
Journal:  Gut       Date:  1965-04       Impact factor: 23.059

2.  Gut mucosal lymphocytes in inflammatory bowel disease: isolation and preliminary functional characterization.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

3.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.

Authors: 
Journal:  Am J Dig Dis       Date:  1975-06

4.  Leukocyte migration test in Crohn's disease, ulcerative colitis, and ankylosing spondylitis using Crohn's colon homogenate, mitochondrial, and microsomal fractions.

Authors:  M J Williams; E R Richens; K R Gough; R J Ancill
Journal:  Am J Dig Dis       Date:  1975-05

5.  Histopathology of cell mediated immune reaction in mouse colon--allograft rejection.

Authors:  R J Holden; A Ferguson
Journal:  Gut       Date:  1976-09       Impact factor: 23.059

6.  Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel disease.

Authors:  P R Gibson; E van de Pol; W Pullman; W F Doe
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

7.  Peripolesis followed by cytotoxicity in chronic idiopathic inflammatory bowel disease.

Authors:  M M Wilders; H A Drexhage; M Kokjé; H W Verspaget; S G Meuwissen
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

8.  K-Cell activity in lamina proprial lymphocytes from the human colon.

Authors:  M Chiba; R G Shorter; W R Thayer; W Bartnik; S ReMine
Journal:  Dig Dis Sci       Date:  1979-11       Impact factor: 3.199

9.  Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis.

Authors:  F Takahashi; K M Das
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

10.  The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels.

Authors:  H J Hodgson; D P Jewell
Journal:  Am J Dig Dis       Date:  1978-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.